Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stevens

Showing results (111-120 of 295) with videos related to

Pageof 30
Sort By:
AIDS (London, England)|January 22, 2009
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South AfricaSinéad Delany, Nonkululeko Mlaba, Tim Clayton, et al.
Biomedicines|October 29, 2025
Diagnostic Accuracy of the Cobas<sup>®</sup> MTB and Cobas MTB/RIF-INH Assays on Sputum and the Cobas MTB Assay on Tongue Swabs for <i>Mycobacterium tuberculosis</i> Complex Detection in Symptomatic Adults in South AfricaAnura David, Lyndel Singh, Manuel Pedro da Silva, et al.
Cytometry. Part B, Clinical Cytometry|January 30, 2008
CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohortDeborah K Glencross, George Janossy, Lindi M Coetzee, et al.
Journal of the International AIDS Society|August 11, 2015
CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysisNathan Ford, Kathryn Stinson, Howard Gale, et al.
Plos One|December 11, 2013
Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trialPrudence Ive, William MacLeod, Nompumelelo Mkumla, et al.
Chest|June 21, 2021
Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic SclerosisSabrina Hoa, Sasha Bernatsky, Murray Baron, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosisNicolas Richard, Geneviève Gyger, Sabrina Hoa, et al.
Journal of Immunological Methods|July 9, 2021
Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune responseAnura David, Lesley Scott, Sarika Jugwanth, et al.
Plos Medicine|August 5, 2011
Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyLesley E Scott, Kerrigan McCarthy, Natasha Gous, et al.
African Journal of Laboratory Medicine|November 7, 2022
Optimising courier specimen collection time improves patient access to HIV viral load testing in South AfricaSarah J Girdwood, Thomas Crompton, Naseem Cassim, et al.
Pageof 30

Showing results (111-120 of 295) with videos related to

Sort By:
Pageof 30
AIDS (London, England)|January 22, 2009
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South AfricaSinéad Delany, Nonkululeko Mlaba, Tim Clayton, et al.
Biomedicines|October 29, 2025
Diagnostic Accuracy of the Cobas<sup>®</sup> MTB and Cobas MTB/RIF-INH Assays on Sputum and the Cobas MTB Assay on Tongue Swabs for <i>Mycobacterium tuberculosis</i> Complex Detection in Symptomatic Adults in South AfricaAnura David, Lyndel Singh, Manuel Pedro da Silva, et al.
Cytometry. Part B, Clinical Cytometry|January 30, 2008
CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohortDeborah K Glencross, George Janossy, Lindi M Coetzee, et al.
Journal of the International AIDS Society|August 11, 2015
CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysisNathan Ford, Kathryn Stinson, Howard Gale, et al.
Plos One|December 11, 2013
Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trialPrudence Ive, William MacLeod, Nompumelelo Mkumla, et al.
Chest|June 21, 2021
Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic SclerosisSabrina Hoa, Sasha Bernatsky, Murray Baron, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosisNicolas Richard, Geneviève Gyger, Sabrina Hoa, et al.
Journal of Immunological Methods|July 9, 2021
Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune responseAnura David, Lesley Scott, Sarika Jugwanth, et al.
Plos Medicine|August 5, 2011
Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyLesley E Scott, Kerrigan McCarthy, Natasha Gous, et al.
African Journal of Laboratory Medicine|November 7, 2022
Optimising courier specimen collection time improves patient access to HIV viral load testing in South AfricaSarah J Girdwood, Thomas Crompton, Naseem Cassim, et al.
Pageof 30